Carcinoma News and Research

RSS

Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.

New approaches to treat aggressive NUT midline carcinoma

Precision medicine, which custom-tailors therapies to the needs of individual patients, is becoming more and more important in cancer therapy. Today, molecular-biological diagnostics can precisely identify alterations in tumor cells.

26 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

14 Sep 2017

Combination immunotherapy shows better overall survival in kidney cancer patients

A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.

13 Sep 2017

Multigene panel test could be useful to detect patients with hereditary kidney cancer syndrome

A multigene panel test could be a useful diagnostic tool to help clinicians identify patients with a hereditary kidney cancer syndrome, according to the results of a study published in Cancer.

13 Sep 2017

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

An International Journal of Cancer study found that female survivors of certain types of cancer have higher risks of poor outcomes in pregnancies conceived after diagnosis than women without cancer.

12 Sep 2017

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the ARIEL3 trial reported today at the ESMO 2017 Congress in Madrid.

8 Sep 2017

Penn researcher wins National Cancer Institute Outstanding Investigator Award

M. Celeste Simon, PhD, who studies cancer cell metabolism, tumor immunology, and the influence of oxygen availability and deprivation on tumor growth, has been given a National Cancer Institute Outstanding Investigator Award.

8 Sep 2017

Researchers compare outcomes of liver resection with transplantation for hepatocellular cancers

Liver transplantation is the gold standard for treating early hepatocellular cancers. Because of the lack of donors, this option is, however, available to a limited degree only.

8 Sep 2017

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.

6 Sep 2017

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

European women with ovarian cancer can safely stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be presented at the ESMO 2017 Congress in Madrid.

4 Sep 2017

Writing your way through cancer

When Lynn Scozzari wrote the beginning lines of that poem, "The Offering," in 2013, she was staring at a photo of a naked woman seated on a rock, her arms thrust open to a valley below. Scozzari herself was in a conference room of the cancer center at Scripps Green Hospital in La Jolla, Calif., seated at a table stocked with coffee and tissues.

26 Aug 2017

Study findings could one day help doctors better predict survival of liver cancer patients

A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, which often happens during liver-cancer development, the activity of certain cancer-promoting genes goes up.

23 Aug 2017

New clinical trial to test cancer drug in patients with advanced solid tumors

A clinical trial to test a new cancer drug in patients with advanced solid tumors, launches in four centers across the UK today (Wednesday), through Cancer Research UK's Center for Drug Development.

23 Aug 2017

Female patients with esophageal cancer have superior response to treatment, study reveals

Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery.

22 Aug 2017

Review of kidney cancer incidence in California signals end of a trend

A review of kidney cancer in California from 1988 through 2013 by the UC Davis Institute for Population Health Improvement has concluded that the high incidence of small tumors and early-stage disease observed in California from 1988 until about 2009 has declined and stabilized in recent years, signaling the end of a trend.

18 Aug 2017

Carcinoma News and Research

Further Reading

New approaches to treat aggressive NUT midline carcinoma

FDA grants approval for new biosimilar to treat multiple types of cancer

Combination immunotherapy shows better overall survival in kidney cancer patients

Multigene panel test could be useful to detect patients with hereditary kidney cancer syndrome

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Penn researcher wins National Cancer Institute Outstanding Investigator Award

Researchers compare outcomes of liver resection with transplantation for hepatocellular cancers

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

Writing your way through cancer

Study findings could one day help doctors better predict survival of liver cancer patients

New clinical trial to test cancer drug in patients with advanced solid tumors

Female patients with esophageal cancer have superior response to treatment, study reveals

Review of kidney cancer incidence in California signals end of a trend

Research provides clues to how infectious bacteria may increase risk of cancer

Researchers identify gene that could play role in energy requirements of liver cancer cells

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Researchers find racial and gender disparities in survival of patients with anal cancer

Immune ‘hotspots’ could help predict the risk of breast cancer relapse in patients, study finds

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News